Semi-synthetic cannabinoid HHC reclassified as an illegal drug
This means the import, export, production, possession, sale and supply of products containing HHC is now illegal.
HHC is a semi-synthetic cannabinoid that has similar effects to cannabis and has been sold as e-cigarettes or vape pens, in herbal mixtures, oils, edible jellies and cakes and as tinctures.
Since it was first detected in Ireland in 2022, it has been linked with episodes of psychosis and hospitalisation.
READ MORE
A recent study by researchers at University Hospital Galway found HHC was the second-most common drug used by patients presenting with psychosis over a 21-month period.
It is one of 14 new substances, including synthetic opioids and semi-synthetic cannabinoids, that have been newly classified as controlled drugs. This follows their identification by the
EU
and by the UN Commission for Narcotic Drugs as posing a serious risk to public health.
The addition of these substances to the Schedules of the Misuse of Drugs Acts gives added powers of enforcement to An Garda Síochána combating the trade in illicit drugs.
Minister for Health
Jennifer Carroll MacNeill
said the sale of HHC as vapes, in attractive packaging or in edible form, is 'a marketing ploy aimed at young people, which masks the fact that this drug is harmful for youth mental health and can be addictive.
'Under the successor national drugs strategy, I'm committed to reviewing legal avenues to respond faster and more effectively to emerging threats from the volatile drugs market,' she said.
'In line with our health-led approach to drug use, our priority is to advance measures that enable us to protect and support the health of our population.'
Minister of State at the Department of Health Jennifer Murnane O'Connor described HHC as 'a grave threat to public health'.
'Controlling HHC and other harmful substances is an important step, that must be complemented by education and prevention programmes so that young people and parents are better informed about the risks associated with drug use,' she said.
Minister of State for Mental Health Mary Butler said: 'Measures like this are essential to easing the pressure on our mental health services and protecting individuals, especially those unaware of the risks, from avoidable and significant harm.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
4 hours ago
- Irish Examiner
Ireland finally bans HCC 'but we must be vigilant about new drugs'
The Government has been urged to remain vigilant and responsive to new drugs trends after it banned an addictive cannabis substitute which has been commonly sold in vapes or as edibles and which has been linked to serious medical episodes and psychosis in young people. The classification of hexahydrocannabinol (HHC) as an illegal drug, agreed by Cabinet on Tuesday, means the import, export, production, possession, sale, or supply of products containing HHC is now illegal, giving added powers of enforcement to gardaí. Addiction experts and youth workers welcomed the move but said enforcement, vigilance, and a swift response by Government to new drug trends will be vital. Former lord mayor of Cork and now youth services manager with Cork Education and Training Board, Mick Finn, said: This move addresses the HHC products that are in plain sight. Mr Finn held a forum on heroin use in Cork while in office and has called for controls on HHC products. 'The big challenge will be enforcement, to ensure that certain shops can't stock these products anymore,' he said. 'HHC products were having a big impact on the ground, and it was reflected in all the stats, so Government and all the relevant agencies need to be more vigilant and responsive to any new trends that emerge from this ban.' Highly addictive and widely available, HHC is a semi-synthetic cannabinoid that has similar effects to cannabis and has been commonly sold as e-cigarettes or vape pens, in herbal mixtures, oils, edible jellies, and cakes, and as tinctures. Since it was first detected in Ireland in 2022, it has been linked with episodes of psychosis and hospitalisation, including one incident at a secondary school in North Cork in late 2023 when four teenagers were hospitalised after falling ill — one of at least 20 similar incidents reported at schools and in recreational settings across the country that same year. A recent 'Irish Examiner' investigation highlighted the ease with which people, including children, could buy products containing HHC. Earlier this year, 'Irish Examiner' reporter Ann Murphy exposed how easy it was to buy HHC in Ireland — and the devastating effects the drug can have. See link above. It also detailed how a 12-year-old child in Clonakilty, West Cork, could not remember his mother's name, while another had to be admitted to a psychiatric hospital after vaping the cannabinoid. A recent study by researchers in University Hospital Galway also found that HHC was the second most common drug used by patients presenting with psychosis over a 21-month period. Consultant psychiatrist Colin O'Gara warned earlier this year that HHC can have devastating effects on a young person's mental health, and that young men suffering from severe psychosis as a result of vaping HHC have required months of intensive treatment in in-patient settings. HHC has now been classified as an illegal drug after health minister Jennifer Carroll MacNeill brought a memo to Cabinet on Tuesday seeking to have it categorised as a Schedule 1 controlled drug under the Misuse of Drugs Act 1977. 14 substances added to proscribed list It is one of 14 substances, including synthetic opioids and semi-synthetic cannabinoids, newly classified as controlled drugs, after the EU and the UN Commission for Narcotic Drugs identified them as posing a serious risk to public health. Addiction counsellor Michael Guerin welcomed the ban but warned that the trade will now go underground. 'It is a positive development because there has been nothing heretofore,' he said. 'Now, it's up to the authorities to enforce the legislation. "The banning of head shops was successful, and I hope the same will happen with HHC. 'The concerning thing about these HHC products was that they seemed to be aimed at the very young, and any research into mood-altering substances in adolescents shows that the effects are more profound, and predisposes them to more serious problems later on. 'But the people making money out of HHC won't go away because of this. But it's better the substances are on the list than not on the list.'
The Irish Sun
7 hours ago
- The Irish Sun
What is synthetic cannabinoid HHC and why has it been classified as illegal drug in Ireland by the Government?
HERE'S everything you need to know about HHC, the synthetic cannabinoid that's been banned by the government. Also known as Hexahydrocannabinol, the Advertisement 3 The substance originally comes from the cannabis plant Credit: Alamy 3 The drug can be sold in e-cigarettes, vapes, jellies, and cakes Credit: Alamy It's a semi-synthetic cannabinoid which comes from the It has joined a list of 13 other substances categorised under the Misuse of Drugs Act 1977 as a Schedule 1 controlled drug. The 14 substances were identified by the This means that the export, import, possession, production, sale, or supply of the product is banned. Advertisement READ MORE IN IRISH NEWS This is because the substance produces many of the same effects as cannabis, another banned drug in Ireland. The Collapse, withdrawals after frequent use, and a stronger type of intoxication than cannabis are also potential side effects. According to the Department of Advertisement Most read in The Irish Sun The substance was first detected in Ireland in 2022. Since then, it has been sold in the form of e-cigarettes, vape pens, oils, herbal mixtures, and jellies. What do cannabis plants look and smell like? But health bosses told They said: "Researchers in University Hospital Advertisement The National Drug Treatment Recording System estimate that between January 1, 2024 and July 25, 2025, 221 cases were reporting HHC as a main or additional problem drug. And there are concerns that HHC is reaching a younger audience of teenagers. NEGATIVE IMPACT Similar to disposable It's also believed that consistently using the substance can have a negative impact on the user's mental health. Advertisement And Health Minister Jennifer Carroll MacNeill welcomed the move. She said: 'The sale of HHC as vapes, in attractive packaging, or in edible jelly form, is a marketing ploy aimed at young people, which masks the fact that this drug is harmful for youth 'HEALTH-LED APPROACH' 'Under the successor national drugs strategy, I'm committed to reviewing legal avenues to respond faster and more effectively to emerging threats from by the volatile drugs market. "In line with our health-led approach to drug use, our priority is to advance measures that enable us to protect and support the health of our population.' Advertisement Minister for Mental Health Mary Butler said: "A recent study showed HHC was involved in a third of first-time psychosis cases at University "This is clear evidence of the serious harm it can cause. "Classifying HHC as a Schedule 1 controlled drug will curtail its availability and reduce its health impact, particularly on the mental health of younger people. "Measures like this are essential to easing the pressure on our mental health services and protecting individuals, especially those unaware of the risks, from avoidable and significant harm." Advertisement 3 HHC has now been labelled an illegal substance in Ireland Credit: Alamy
Irish Examiner
9 hours ago
- Irish Examiner
MSD won't close Irish sites as part of $3bn cutbacks
Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. MSD yesterday announced a global cost-cutting exercise as it prepares for generic competition to its Irish-manufactured cancer drug Keytruda, the world's best-selling medicine, which is predominantly made in Ireland. The company will cut administrative, sales and research jobs, with increased focus on the US market. It has not said where the roles will be lost or if any Irish workers will be among those affected. However, a spokesperson told the Irish Examiner: "The restructuring announced today does not include site closures in Ireland." MSD employs more than 3,000 people at eight locations in Ireland. These include MSD Brinny in Co Cork specialising in development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines; three facilities in Dublin (MSD Biotech, MSD Blackrock, and MSD Red Oak North); MSD Carlow; MSD Dunboyne in Co Meath; MSD Ballydine in Co Tipperary, the company's first Irish site; and MSD Dundalk, the former WuXi Vaccines sites acquired in January. The cost cuts will include $1.7bn (€1.47bn) in annual savings from the elimination of certain administrative, sales and R&D positions, MSD said. The company expects the restructuring to be completed by the end of 2027, the year before Keytruda's key patents expire and the drug faces US government price cuts. The company said it plans to reinvest the savings into developing new drugs and launching new products. EU-branded medicines will face 15% import tariffs under the new transatlantic trade deal agreed between the European bloc and the US at the weekend. Like many other pharmaceutical firms based in Ireland, MSD had stockpiled doses of Keytruda manufactured in Ireland, to protect itself from tariffs imposed in 2025. MSD previously disclosed plans to invest more than $9bn (€7.78bn) in US manufacturing over the next four years, part of an effort to make more of its medicines in the US. The company reiterated that it expects to spend $200m (€172m) on tariffs in 2025, a number that reflects levies already in place and doesn't account for future tariffs on pharmaceuticals.
